Fusion protein comprising an interleukin-2 fragment ballast portion
AssigneeHoechst Aktiengesellschaft
InventorsPaul Habermann, Friedrich Wengenmayer
Life of this patent
Estimating the term…
Loading patent…
AssigneeHoechst Aktiengesellschaft
InventorsPaul Habermann, Friedrich Wengenmayer
Estimating the term…
A fusion protein including a ballast portion and a desired protein. The ballast portion forms either the C- or N-terminus of the fusion protein, and the ballast portion includes a part of the amino acid sequence of interleukin-2 (IL-2). According to certain preferred embodiments, the ballast portion includes approximately the first 100 amino acids of IL-2. According to other preferred embodiments, the ballast portion contains fewer than 100 amino acids of IL-2. According to further advantageous embodiments, a synthetic IL-2 gene is divided by unique cleavage sites into 6 segments, any number of these segments can be linked in arbitrary sequence. These embodiments permit specific instructions with which the solubility of the fusion protein can be altered, and thus the fusion proteins can readily be separated from soluble proteins intrinsic to a host. The DNA coding for the fusion proteins, as well as vectors and hosts are also provided.
A fusion protein comprising a ballast portion and a desired protein, said ballast portion forming the N-terminus of the fusion protein and said ballast portion consisting essentially of residues of the amino acid sequence of interleukin-2 (IL-2), wherein said ballast portion contains at least a 22-residue amino acid sequence of IL-2 and lacks IL-2 biological activity in the T-cell proliferation test.
Dependencies are inferred from the claim text.